References
- Vyvanse® (lisdexamfetamine dimesylate) [prescribing information]Lexington, MAShire US Inc2017
- McElroySLHudsonJFerreira-CornwellMCRadewonukJWhitakerTGasiorMLisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trialsNeuropsychopharmacology20164151251126026346638
- CitromeLLisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Int J Clin Pract201569441042125752762
- GoodmanDFaraoneSVAdlerLADirksBHamdaniMWeislerRInterpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of lisdexamfetamine dimesylate in ADHDPrim Psychiatry20101734452
- LeuchtSKaneJMKisslingWHamannJEtschelEEngelRClinical implications of Brief Psychiatric Rating Scale scoresBr J Psychiatry200518736637116199797
- FurukawaTAShearMKBarlowDHEvidence-based guidelines for interpretation of the Panic Disorder Severity ScaleDepress Anxiety2009261092292919006198
- LeuchtSKaneJMEtschelEKisslingWHamannJEngelRRLinking the PANSS, BPRS, and CGI: clinical implicationsNeuropsychopharmacology200631102318232516823384
- BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther200729345046317577466
- AdlerLAGoodmanDWKollinsSHDouble-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry20086991364137319012818
- BerkMNgFDoddSThe validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useJ Eval Clin Pract200814697998318462279
- BusnerJTargumSDThe clinical global impressions scale: applying a research tool in clinical practicePsychiatry (Edgmont)2007472837
- GuyWClinical Global ImpressionsRockville, MDUS Department of Health, Education, and Welfare; Public Health Service; Alcohol, Drug Abuse and Mental Health Administration; NIMH Psychopharmacology Research Branch1976
- DealLSWirthRJGasiorMHermanBKMcElroySLValidation of the Yale-Brown Obsessive Compulsive Scale modified for binge eatingInt J Eat Disord2015487994100426032442
- GoodmanWKPriceLHRasmussenSAThe Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliabilityArch Gen Psychiatry19894611100610112684084
- McElroySLMitchellJEWilfleyDLisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorderEur Eat Disord Rev201524322323126621156
- McElroySLArnoldLMShapiraNATopiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialAm J Psychiatry2003160225526112562571
- McElroySLGuerdjikovaAKotwalRAtomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trialJ Clin Psychiatry200768339039817388708
- McElroySLHudsonJICapeceJATopiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled studyBiol Psychiatry20076191039104817258690
- McElroySLHudsonJIMalhotraSWelgeJANelsonEBKeckPEJrCitalopram in the treatment of binge-eating disorder: a placebo-controlled trialJ Clin Psychiatry200364780781312934982
- McElroySLKotwalRGuerdjikovaAIZonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trialJ Clin Psychiatry200667121897190617194267